Relationship between low-density lipoprotein cholesterol level on admission and in-hospital mortality in patients with ST-segment elevation myocardial infarction, with or without diabetes, treated with percutaneous coronary intervention

Kardiologia Polska

Volumn 68, Issue 9, 2010, Pages 1005-1012

  Pres, Damian ^a   Ga̧sior, Mariusz ^a   Lekston, Andrzej ^a   Gierlotka, Marek ^a   Hawranek, Michał ^a   Tajstra, Mateusz ^a   Buchta, Piotr ^a   Słonka, Grzegorz ^a   Poloński, Lech ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Diabetes mellitus; Low density lipoprotein cholesterol; Myocardial infarction

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NITRATE; THIENOPYRIDINE DERIVATIVE; TRIACYLGLYCEROL;

ADULT; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

EID: 77958588582     PISSN: 00229032     EISSN: 00229032     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. nd Ed. D.C.: Government Printing Office, Washington, 1995: 429-448.
2. Haffner SM, Lehto S, Rönnemaa T et al. Mortality from coronary heart disease in subjects with type 2 diabetes and in non-diabetic subjects with and without prior myocardial infarction. N Engl J Med, 1998; 339: 229-234. (Pubitemid 28350165)
3. Harjai KJ, Stone GW, Boura J et al. Comparison of outcomes of diabetic and non-diabetic patients undergoing primary angioplasty for acute myocardial infarction. Am J Cardiol, 2003; 91: 1041-1045. (Pubitemid 36514916)
4. Katayama T, Nakashima H, Takagi C et al. Clinical outcomes and left ventricular function in diabetic patients with acute myocardial infarction treated by primary coronary angioplasty. Int Heart J, 2005; 46: 607-618.
5. Stuckey TD, Stone GW, Cox DA et al. Impact of stenting and abciximab in patients with diabetes mellitus undergoing primary angioplasty in acute myocardial infarction (the CADILLAC trial). Am J Cardiol, 2005; 95: 1-7.
6. Howard BV. Pathogenesis of dibetic dyslipidemia. Diabetes Rev, 1995; 3: 423-432.
7. Howard BV, Robbins DC, Sievers ML et al. LDL cholesterol as a strong predictor of coronary heart disease in diabetic individuals with insulin resistance and low LDL: the Strong Heart Study. Arterioscler Thromb Vasc Biol, 2000; 20: 830-835.
8. Maruyama K, Hirobe K, Noda H et al. Associations between blood lipid profiles and risk of myocardial infarction among Japanese male workers: 3M Study. J Atheroscler Thromb, 2009; 16: 714-721.
9. Al-Mallah MH, Hatahet H, Cavalcante JL et al. Low admission LDL-cholesterol is associated with increased 3-year all-cause mortality in patients with non ST segment elevation myocardial infarction. Cardiol J, 2009; 16: 227-233.
10. Akosah KO, Cerniglia RM, Havlik P et al. Myocardial infarction in young adults with low-density lipoprotein cholesterol levels < or = 100 mg/dL: clinical profile and 1-year outcomes. Chest, 2001; 120: 1953-1958.
11. Olsson AG, Schwartz GG, Szarek M et al. High-density lipoprotein, but not low-density lipoprotein cholesterol levels influence short-term prognosis after acute coronary syndrome: results from the MIRACL trial. Eur Heart J, 2005; 26: 890-896.
12. Wang TY, Newby LK, Chen AY et al. Hypercholesterolemia paradox in relation to mortality in acute coronary syndrome. Clin Cardiol, 2009; 32: E22-E28.
13. Correia LC, Rocha MS, Esteves JP. HDL-cholesterol level provides additional prognosis in acute coronary syndromes. Int J Cardiol, 2009; 136: 307-314.
14. The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. TIMI Study Group. N Engl J Med, 1985; 312: 932-936.
15. Pikto-Pietkiewicz W, Pasierski T. Patofizjologia zaburzeń lipidowych cukrzycy. In: Narkiewicz K. Diabetokardiologia. Medycyna Praktyczna, Kraków 2004: 89-102.